About
Single Cell Analysis Without Complex Instrumentation
Areas of Focus
Categories
Non-PharmaceuticalBoston & New England
Clinical Trials (2)
View allTotal Trials
2
As Lead Sponsor
1
As Collaborator
1
Total Enrollment
160
By Phase
PHASE2: 1
By Status
RECRUITING: 1COMPLETED: 1
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
Today
Hover over trial bars to see details
Recent Trials
NCT06653777Collaborator
Efficacy of Pemigatinib in Patients With Solid Tumors Characterized by an Alteration of the Gene FGFR in Tumor Cells
PHASE2Recruiting
40 participants
Started: Mar 27, 2025 · Completed: Jun 30, 2028
NCT04048564Lead Sponsor
Observational Study on CML Patients in Any Phase of the Disease Treated With Ponatinib (Iclusig®)
N/ACompleted
120 participants
Started: Feb 23, 2018 · Completed: Jul 3, 2023
Locations (1)
Headquarters
Watertown, MA, United States
Map
Loading map...